SCHEMBL29924022

SCHEMBL29924022

NC(=O)c1csc(-c2cnn(CO)c2)n1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.46
HTR2B P41595 1/20 0.43
ACHE P22303 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.39
DPP4 P27487 1/20 0.38
PIM1 P11309 1/20 0.37
CYP2C9 P11712 1/20 0.37
SCN9A Q15858 1/20 0.37
CLK2 P49760 1/20 0.37
LRRK2 Q5S007 1/20 0.37
BTK Q06187 2/20 0.36
ALDH1A1 P00352 2/20 0.35
HPGDS O60760 1/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31122140 0.89 HTR2B (0.45) CYP2C19HTR2BACHEIRAK4DPP4
SCHEMBL31122120 0.80 CLK2 (0.54) CYP2C19HTR2BACHEIRAK4CLK2
SCHEMBL31708330 0.78 TLR7 (0.46) IRAK4ALDH1A1HPGD
SCHEMBL31122131 0.77 CYP2C19 (0.39) CYP2C19HTR2BACHEIRAK4DPP4
SCHEMBL31122115 0.75 HPGDS (0.40) CYP2C19IRAK4PIM1HPGDS
SCHEMBL25510326 0.75 GRM2 (0.57) CYP2C19HTR2BACHECYP2C9SCN9A
Formic Acid SCHEMBL31708331 0.75 TLR7 (0.43) IRAK4ALDH1A1HPGD
SCHEMBL31122144 0.70 HTR2C (0.42) CYP2C19HTR2BACHEIRAK4CLK2
SCHEMBL168519 0.69 HTR2B (0.66) CYP2C19HTR2BACHECYP2C9SCN9A
SCHEMBL6202834 0.69 HPGD (0.64) CYP2C19HTR2BACHEIRAK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118510771-A IRAK inhibitors for the treatment of conditions associated with cytokine release associated with respiratory viral infection 里格尔药品股份有限公司 2024-08-16 CN disclosed
WO-2022187303-A1 A METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUND OR FORMULATION THEREOF RIGEL PHARMACEUTICALS, INC. (US) 2022-09-09 WO disclosed